Why the study?
Does a biodegradable polymer-based sirolimus-eluting stent prevent angiographic restenosis in patients with coronary artery lesions?
Population
100 patients with coronary artery lesions
Design
Cohort, non-randomised, open label
Follow-up
30 months
Authors
Loading...
Supports use in selected lesions; leaves open randomized confirmation of restenosis prevention.
Does a biodegradable polymer-based sirolimus-eluting stent prevent angiographic restenosis in patients with coronary artery lesions?
The biodegradable-polymer-based sirolimus-eluting stent effectively inhibits neointimal hyperplasia with low rates of restenosis and MACE up to 30 months.
Dani et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: